This 3-hour session takes places during the DIA Europe 2025 and gives innovators the opportunity to learn about pathways to communicate effectively with Regulatory Authorities and HTA bodies and discuss challenges in the development of innovative healthcare products. Industry experts, Regulators, HTA Body representatives and patient advocates will share insights into overcoming regulatory hurdles and the benefits of early collaboration in fostering specialised drug development.
Innovators receive a free day pass to this session and the first day of DIA Europe 2025 (1 pass per company)
115
Days10
Hours47
MinutesBasel-Stadt, Switzerland